Skip to main content

GoodRx shares plunge 39% after revenue miss, weak forecast

Discount drug prescription site GoodRx plunged 39% after the company missed estimates on revenue and gave a weak forecast.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.